Biomarkers for dementia in Latin American countries: Gaps and opportunities
MA Parra, P Orellana, T Leon, CG Victoria… - Alzheimer's & …, 2023 - Wiley Online Library
Limited knowledge on dementia biomarkers in Latin American and Caribbean (LAC)
countries remains a serious barrier. Here, we reported a survey to explore the ongoing work,
needs, interests, potential barriers, and opportunities for future studies related to biomarkers.
The results show that neuroimaging is the most used biomarker (73%), followed by genetic
studies (40%), peripheral fluids biomarkers (31%), and cerebrospinal fluid biomarkers
(29%). Regarding barriers in LAC, lack of funding appears to undermine the implementation …
countries remains a serious barrier. Here, we reported a survey to explore the ongoing work,
needs, interests, potential barriers, and opportunities for future studies related to biomarkers.
The results show that neuroimaging is the most used biomarker (73%), followed by genetic
studies (40%), peripheral fluids biomarkers (31%), and cerebrospinal fluid biomarkers
(29%). Regarding barriers in LAC, lack of funding appears to undermine the implementation …
Biomarkers for dementia in Latin American countries: Gaps andopportunities
MA Parra, P Orellana, T León, CG Victoria, F Henriquez… - 2023 - repositorio.udd.cl
Limited knowledge on dementia biomarkers in Latin American and Caribbean (LAC)
countries remains a serious barrier. Here, we reported a survey to explore the ongo-ing
work, needs, interests, potential barriers, and opportunities for future studiesrelated to
biomarkers. The results show that neuroimaging is the most used biomarker (73%), followed
by genetic studies (40%), peripheral fluids biomarkers (31%), and cere-brospinal fluid
biomarkers (29%). Regarding barriers in LAC, lack of funding appears toundermine the …
countries remains a serious barrier. Here, we reported a survey to explore the ongo-ing
work, needs, interests, potential barriers, and opportunities for future studiesrelated to
biomarkers. The results show that neuroimaging is the most used biomarker (73%), followed
by genetic studies (40%), peripheral fluids biomarkers (31%), and cere-brospinal fluid
biomarkers (29%). Regarding barriers in LAC, lack of funding appears toundermine the …
以上显示的是最相近的搜索结果。 查看全部搜索结果